These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6607110)

  • 41. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
    Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
    Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2'-deoxycoformycin. A new anticancer agent.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    Cancer Clin Trials; 1981; 4(2):209-13. PubMed ID: 7018725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
    Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
    [No Abstract]   [Full Text] [Related]  

  • 44. Biochemical basis for the differential effects of deoxycoformycin on human leukemias.
    Yu AL; Matsumoto S; Bleeker L; Alvarez A; Bakay B; Nyhan WL; Kung F
    Adv Exp Med Biol; 1984; 165 Pt B():305-8. PubMed ID: 6609536
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
    Biochem Biophys Res Commun; 1985 Mar; 127(3):1019-25. PubMed ID: 3872657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.
    Siaw MF; Coleman MS
    J Biol Chem; 1984 Aug; 259(15):9426-33. PubMed ID: 6204981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenosine, deoxyadenosine, and deoxyguanosine induce DNA cleavage in mouse thymocytes.
    Kizaki H; Shimada H; Ohsaka F; Sakurada T
    J Immunol; 1988 Sep; 141(5):1652-7. PubMed ID: 3261757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of X-ray-induced potentially lethal damage (PLD) repair by cordycepin (3'-deoxyadenosine) and enhancement of its action by 2'-deoxycoformycin in Chinese hamster hai cells in the stationary phase in vitro.
    Nakatsugawa S; Sugahara T
    Radiat Res; 1980 Nov; 84(2):265-75. PubMed ID: 6969408
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of adenosine deaminase by azapurine ribonucleosides.
    Shewach DS; Krawczyk SH; Acevedo OL; Townsend LB
    Biochem Pharmacol; 1992 Nov; 44(9):1697-700. PubMed ID: 1449528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of DNA strand breaks and cross-links by 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone in Chinese hamster ovary cells.
    King CL; Hittelman WN; Loo TL
    Cancer Res; 1984 Dec; 44(12 Pt 1):5634-7. PubMed ID: 6498824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias.
    Ganeshaguru K; Ho AD; Piga A; Catovsky D; Hoffbrand AV
    Leuk Res; 1987; 11(10):941-5. PubMed ID: 3500370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activated T lymphocytes resist the toxic effects of the adenosine deaminase inhibitor, 2-deoxycoformycin.
    Kotb M; Veit BC
    Cell Immunol; 1982 Sep; 72(1):64-76. PubMed ID: 6983389
    [No Abstract]   [Full Text] [Related]  

  • 55. Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Hershfield MS; Kurtzberg J; Harden E; Moore JO; Whang-Peng J; Haynes BF
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):253-7. PubMed ID: 6607471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. UV- and gamma-irradiation-induced DNA single-strand breaks and their repair in human blood granulocytes and lymphocytes.
    Lankinen MH; Vilpo LM; Vilpo JA
    Mutat Res; 1996 Jun; 352(1-2):31-8. PubMed ID: 8676912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of apoptosis in early mouse embryos by 2'-deoxyadenosine exposure.
    Gao X; Blackburn MR; Knudsen TB
    Teratology; 1994 Jan; 49(1):1-12. PubMed ID: 8171392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
    Niitsu N; Umeda M; Honma Y
    Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).
    Dang-Vu AP; Olsen EA; Vollmer RT; Greenberg ML; Hershfield MS
    J Am Acad Dermatol; 1988 Oct; 19(4):692-8. PubMed ID: 3263401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical pharmacology and toxicology of formycin alone and in combination with 2'-deoxycoformycin (pentostatin).
    Spremulli EN; Crabtree GW; Dexter DL; Chu SH; Farineau DM; Ghoda LY; McGowan DL; Diamond I; Parks RE; Calabresi P
    Cancer Treat Rep; 1983 Mar; 67(3):267-74. PubMed ID: 6600968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.